Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Denis

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
Cancer Letters|May 25, 2005
The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatmentDelphine Bouancheau, Bruno Buecher, Anne Jarry, et al.
International Journal of Oncology|January 6, 2011
PPARγ is functionally expressed in clear cell renal cell carcinomaNicolas Collet, Sandrine Théoleyre, Julie Rageul, et al.
International Journal of Oncology|March 27, 2012
Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomasDelphine Loussouarn, Anne-Gaëlle Le Loupp, Jean-Sébastien Frenel, et al.
International Journal of Molecular Medicine|December 17, 2008
TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruptionThomas Fréour, Anne Jarry, Kalyane Bach-Ngohou, et al.
Kidney International|June 6, 2003
Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxideAnne Jarry, Karine Renaudin, Marc G Denis, et al.
The Journal of Physiology|May 19, 2010
Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2Kalyane Bach-Ngohou, Maxime M Mahé, Philippe Aubert, et al.
Experimental Dermatology|November 28, 2017
BRAF mutations might be more common than supposed in vulvar melanomasSophie Wylomanski, Marc G Denis, Sandrine Théoleyre, et al.
Anticancer Research|April 9, 2005
Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell linesBruno Buecher, Delphine Bouancheau, Alexis Broquet, et al.
Oncology Reports|June 14, 2014
Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patientsMelanie Saint-Jean, Gaëlle Quereux, Jean-Michel Nguyen, et al.
Journal of Neuro-Oncology|May 18, 2013
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experienceJ S Frenel, C Leux, D Loussouarn, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Cancer Letters|May 25, 2005
The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatmentDelphine Bouancheau, Bruno Buecher, Anne Jarry, et al.
International Journal of Oncology|January 6, 2011
PPARγ is functionally expressed in clear cell renal cell carcinomaNicolas Collet, Sandrine Théoleyre, Julie Rageul, et al.
International Journal of Oncology|March 27, 2012
Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomasDelphine Loussouarn, Anne-Gaëlle Le Loupp, Jean-Sébastien Frenel, et al.
International Journal of Molecular Medicine|December 17, 2008
TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruptionThomas Fréour, Anne Jarry, Kalyane Bach-Ngohou, et al.
Kidney International|June 6, 2003
Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxideAnne Jarry, Karine Renaudin, Marc G Denis, et al.
The Journal of Physiology|May 19, 2010
Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2Kalyane Bach-Ngohou, Maxime M Mahé, Philippe Aubert, et al.
Experimental Dermatology|November 28, 2017
BRAF mutations might be more common than supposed in vulvar melanomasSophie Wylomanski, Marc G Denis, Sandrine Théoleyre, et al.
Anticancer Research|April 9, 2005
Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell linesBruno Buecher, Delphine Bouancheau, Alexis Broquet, et al.
Oncology Reports|June 14, 2014
Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patientsMelanie Saint-Jean, Gaëlle Quereux, Jean-Michel Nguyen, et al.
Journal of Neuro-Oncology|May 18, 2013
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experienceJ S Frenel, C Leux, D Loussouarn, et al.
Pageof 19